Understand the applicable PMA pathways for PKD & Thalassemia across the GCC markets and assess the commercial potential for a new product Read more
Understanding the Perception Around FOC Programs Preferred by Payers for SCD Products in the GCC Read more
Understanding Risks for Biosimilars in the MEA Region, and Associated Entry List and Net Prices Read more
Defining the price potential and market access strategy for a new SCD therapy launching in the GCC Read more
